This article is more than 5 years old. Information may no longer be current.

Carl Zeiss posts 7% increase in consolidated revenue for first 9 months of fiscal year

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

JENA, Germany — Carl Zeiss Meditec reported Euro 446.6 million in consolidated revenue for the first 9 months of fiscal 2007-2008, representing a 7% increase compared with Euro 417.6 million during the same period last year, the company announced in a press release.

Consolidated net income for the 9-month period totaled Euro 36.4 million, a 17.3% increase from Euro 31 million reported during the same period last year.

The ophthalmic systems strategic business unit, which accounted for 45.9% of the company's total consolidated revenue during the first 9 months of the fiscal year, posted Euro 205.1 million in consolidated revenue, a 3.4% decline from Euro 212.4 million during the same period last year. The company attributed the decline to the influence of currency exchange rates, as well as the negative economic environment in the United States.

Consolidated revenues generated by the company's surgical ophthalmology strategic business unit for the 9-month period totaled Euro 58.4 million, up 49.4% from Euro 39.1 million for the same period last year. In addition to the strong performance of new products, the higher revenue is due to the initial consolidation of Acri.Tec GmbH, which accounted for 13.1% of the company's total consolidated revenue, an increase compared with 9.4% for the same period in 2006-2007.

The Europe, Middle East and Africa region was the company's strongest sales contributor, posting Euro 159.3 million in consolidated revenue during the 9-month period, up 24.5% compared with Euro 127.9 million reported during the same period last year. In addition to the Acri.Tec consolidation, growth in this region was attributed to sales of diagnostic systems, surgical microscopes and IOLs, the release said.

Consolidated revenue in the Americas region totaled Euro 146.3 million, a 17.1% decline compared with Euro 176.5 million posted during the same period last year. The deficit was largely due to fluctuations in foreign exchange rates, as well as the reluctance of investors in the U.S. market.

Also during the 9-month period, consolidated revenue in the Asia-Pacific region increased 19.6% to Euro 102.4 million, according to the release.